Comparison of lateral transperitoneal versus retroperitoneal laparoscopic adrenalectomy for pheochromocytoma: a single-centre retrospective study

Updates Surg. 2023 Aug;75(5):1259-1266. doi: 10.1007/s13304-023-01475-x. Epub 2023 Feb 26.

Abstract

Laparoscopic adrenalectomy (LA) has became the standardized treatment for pheochromocytoma. The aim of this study was to evaluate outcomes of lateral transperitoneal and retroperitoneal LA for pheochromocytoma. Between January 2011 and December 2021, 142 patients with pheochromocytoma underwent LA via lateral transperitoneal (123 patients) or retroperitoneal (19 patients) approaches. Data of these patients were assessed to investigate the differences in perioperative outcomes and intraoperative haemodynamic parameters between the two procedures. Clinical parameters at presentation were comparable between the two groups, except for tumour size, which was larger in the transperitoneal group (50 [10-115] mm vs 35 [7-110] mm, P = 0.012). There were no significant differences between the two groups in terms of operation time, estimated blood loss, intraoperative transfusion rate, incidence of complications, conversion to open surgery, postoperative analgesic requirement, time to first oral intake, or mean hospital stay. Intraoperative haemodynamic parameters of the two groups were similar. After adjusting for tumour size using propensity score matching, both perioperative outcomes and haemodynamic parameters were still comparable. Lateral transperitoneal and retroperitoneal laparoscopic adrenalectomies provide similar perioperative and haemodynamic outcomes for surgical resection of pheochromocytoma.

Keywords: Adrenalectomy; Laparoscopic; Pheochromocytoma; Retroperitoneal; Transperitoneal.

MeSH terms

  • Adrenal Gland Neoplasms* / pathology
  • Adrenal Gland Neoplasms* / surgery
  • Adrenalectomy / methods
  • Humans
  • Laparoscopy* / methods
  • Pheochromocytoma* / pathology
  • Pheochromocytoma* / surgery
  • Retrospective Studies